The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms

American Journal of Kidney Diseases

Volumn 29, Issue 1, 1997, Pages 153-163

  Wolf, Gunter ^b   Ziyadeh, Fuad N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

angiotensin converting enzyme; Glomerulus; glucose; hypertrophy; mesangial cell; renal tubule; transforming growth factor

Indexed keywords

ANGIOTENSIN;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; HUMAN; KIDNEY BLOOD FLOW; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0031024650     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90023-8     Document Type: Article

References (126)

1. Parving HH, Osterby R, Anderson PW, Hsueh W: Diabetic nephropathy, in Brenner BM (ed): The Kidney (ed 5). Philadelphia, PA, Saunders, 1996, pp 1864-1892
2. Berneger TV, Brancati FL, Whelton PK, Klag MJ: End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 121:912-918, 1994
3. Mogensen CE: Diabetes mellitus and the kidney. Kidney Int 21:673-675, 1982
4. Adler S: Structure-function relationships associated with extracellular matrix alteration in diabetic glomerulopathy. J Am Soc Nephrol 5:1165-1172, 1994
5. Kreisberg JI, Ayo SH: The glomerular mesangium in diabetes mellitus. Kidney Int 43:109-113, 1993
6. Ziyadeh FN: Renal tubular membrane and collagen type IV in diabetes mellitus. Kidney Int 43:114-120, 1993
7. Ziyadeh FN, Goldfarb S: The diabetic renal tubulointerstitium, in Dodd SM (eds): Tubulointerstitial and Cystic Disease of the Kidney. Current Topics in Pathology, vol 88. Heidelberg, Springer, 1995, pp 175-201
8. Wolf G, Thaiss F: Hyperglycemia-pathophysiological aspects at the cellular level. Nephrol Dial Transplant 10:1109-1112, 1995
9. Lewis EJ, Hunsicker LG, Bain RP, Rhode RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
10. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard T, Passa P: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 297:1092-1095, 1988
11. Myers BD, Meyer TW: Angiotensin-converting enzyme inhibitors in the prevention of experimental diabetic glomerulopathy. Am J Kidney Dis 13:20-24, 1989
12. Bakris GL: Angiotensin-converting enzyme inhibitors and the progression of diabetic nephropathy. Ann Intern Med 118:643-644, 1993
13. Remuzzi A, Perico N, Amuchastegui CS, Malanchini B, Mazerska M, Battaglia C, Bertani T, Remuzzi G: Short and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 4:40-49, 1993
14. Dudley CR, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ: UK prospective diabetes study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 48:1907-1911, 1995
15. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F, Passa P, Alhenc-Gelas F: Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic complications. Diabetes 43:384-388, 1994
16. Schmidt S, Schöne N, Ritz E: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47:1176-1181, 1995
17. Navar LG, Rosivall L: Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics. Kidney Int 25:857-868, 1984
18. Mitchell KD, Navar LG: Interactive effects of angiotensin II on renal hemodynamics and tubular reabsorptive function. Kidney Int 38:S69-S73, 1990 (suppl 30)
19. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulosclerosis by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
20. Blantz RC, Gabbai FB: Effect of angiotensin II on glomerular hemodynamics and ultrafiltration coefficient. Kidney Int 31:S108-S11, 1987 (suppl 20)
21. Björck S, Aureel M: Diabetes mellitus, the renin-angiotensin system, and angiotensin-converting enzyme inhibition. Nephron 55:10-20, 1990
22. Epstein M, Sowers JR: Diabetes mellitus and hypertension. Hypertension 19:403-418, 1992
23. Dunn MJ: Prostaglandins, angiotensin II, and proteinuria. Nephron 55:30-37, 1990 (suppl 1)
24. Hsueh WA, Anderson PW: Systemic hypertension and the renin-angiotensin system in diabetic vascular complications. Am J Cardiol 72:14H-21H, 1993
25. Ingelfinger JR, Jung F, Tang SS: Molecular biology techniques and their applicability in the study of diabetes and hypertension: The renin-angiotensin system as an example. J Am Soc Nephrol 3:S18-S26, 1992 (suppl 1)
26. Nakamura T, Takahashi T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H: Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J Am Soc Nephrol 5:1492-1497, 1995
27. Harris RC, Martinez-Maldonado M: Angiotensin II-mediated renal injury. Miner Electrolyte Metab 21:328-335, 1995
28. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 3:1531-1540, 1993
29. Wolf G, Neilson EG: Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 259:F768-F777, 1990
30. Wolf G, Neilson EG: Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells. Kidney Int 43:S100-S107, 1993 (suppl 39)
31. Trujilo A, Eggena P, Barret J, Tuck M: Renin regulation in type II diabetes mellitus: Influence of dietary sodium. Hypertension 13:200-205, 1989
32. Tuck M, Sambhi MP, Levin L: Hyporeninemic hypoaldosteronism in diabetes mellitus. Diabetes 28:237-241, 1979
33. Burden AC, Thurstone H: Plasma renin activity in diabetes mellitus. Clin Sci 56:255-259, 1979
34. Luetscher JA, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M: Increased plasma inactive renin in diabetes mellitus: A marker for microvascular complications. N Engl J Med 312:1412-1417, 1985
35. Amemiya S, Ishihara T, Higashida K, Kusano S, Ohyama K, Kato K: Altered synthesis of renin in patients with insulin-dependent diabetes: Plasma prorenin as a marker predicting the evolution of nephropathy. Diabetes Res Clin Pract 10:115-122, 1990
36. Franken AA, Derkx FH, Man in't Veld AJ, Hop WC, Van Rens GH, Peperkamp E, De Jong PT, Schalekamp MA: High plasma prorenin in diabetes mellitus and its correlation with some complications. J Clin Endocrinol Metab 71:1008-1015, 1990
37. Matinlauri IH, Rönnemaa T, Koskinen PJ, Aaalto MA, Viikari JS, Irjala KM: Elevated serum total renin is insensitive in detecting incipient diabetic nephropathy. Diabetes Care 18:1357-1361, 1995
38. Cohen AJ, Laurens P, Fray JC: Suppression of renin secretion by insulin: Dependence on extracellular calcium. Am J Physiol 245:E531-E534, 1983
39. Jost-Vu E, Horton R, Antonipillai I: Altered regulation of renin secretion by insulinlike growth factors and angiotensin II in diabetic rats. Diabetes 41:1100-1105, 1992
40. Duntas L, Keck FS, Haug C, Hetzel W, Wolf CF, Rosenthal J, Pfeiffer EF: Serum angiotensin-converting enzyme activity and active renin plasma concentrations in insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 16:203-208, 1992
41. Van Dyk DJ, Erman A, Erman T, Chen-Gal B, Sulkes J, Boner G: Increased serum angiotensin converting enzyme activity in type I insulin-dependent diabetes mellitus: Its relation to metabolic control and diabetic complications. Eur J Clin Invest 24:463-467, 1994
42. Liebermann J, Sastre A: Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med 93:825-826, 1980
43. Schernthaner G, Schwarzer C, Kuzmits R, Müller MM, Klemen U, Freyler H: Increased angiotensin-converting enzyme activities in diabetes mellitus: Analysis of diabetes type, state of metabolic control and occurrence of diabetic vascular disease. J Clin Pathol 37:307-312
44. Jandeleit K, Rumble J, Jackson B, Cooper ME: Mesenteric vascular angiotensin-converting enzyme is increased in experimental diabetes mellitus. Clin Exp Pharmacol Physiol 19:343-347, 1992
45. Fishel RS, Thoureani V, Eisenberg SJ, Shai SY, Corson MA, Nabel EG, Bersnetin KE, Berk BC: Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells: Possible mediator of the response to vascular injury. J Clin Invest 95:377-387, 1995
46. Giampietro O, Lenzi S, Sampietro T, Miccoli R, Navalesi R: Serum angiotensin-converting enzyme in diabetes mellitus: A negative report. Enzyme 35:102-105, 1986
47. Kikkawa R, Kitamura E, Fujiwara Y, Haneda M, Shigeta Y: Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats. Renal Physiol 9:187-192, 1986
48. Vallon V, Wead LM, Blantz RC: Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: Effect of sodium and salt restriction. J Am Soc Nephrol 5:1761-1767, 1995
49. Daniels BS, Hostetter TH: Effects of dietary protein intake on vasoactive hormones. Am J Physiol 258:R1095-R1100, 1990
50. Rosenberg ME, Chmielewski D, Hostetter TH: Effect of dietary protein on rat renin and angiotensin gene expression. J Clin Invest 85:1144-1149, 1990
51. Ballermann BJ, Skorecki KL, Brenner BM: Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat. Am J Physiol 247:F110-F116, 1984
52. Wilkes BM: Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: Time course and mechanisms. Endocrinology 120:1291-1298, 1987
53. Cheng HF, Burns KV, Harris RC: Reduced proximal tubule angiotensin II receptor expression in streptozotocin-induced diabetes mellitus. Kidney Int 46:1603-1610, 1994
54. Williams B, Tsai P, Schrier RW: Glucose-induced downregulation of angiotensin II and arginine vasopressin receptors in cultures rat aortic vascular smooth muscle cells: Role of protein kinase C. J Clin Invest 90:1992-1999, 1992
55. Wolf G, Neilson EG, Goldfarb S, Ziyadeh FN: The influence of glucose concentration on angiotensin II-induced hypertrophy of proximal tubular cells in culture. Biochem Biophys Res Commun 176:902-909, 1991
56. 1 receptor by transcriptional and post-transcriptional mechanisms: Evidence for homologous and heterologous regulation. Mol Pharmacol 48:601-609, 1995
57. Murasawa S, Matsubara H, Mori Y, Kijima K, Maruyama K, Inada M: Identification of a negative cis-regulatory element and trans-acting protein that inhibit transcription of the angiotensin II type 1a receptor gene. J Biol Chem 270:24282-24286, 1995
58. Sechi LA, Griffin CA, Schambelan M: The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes 43:1180-1184, 1995
59. Cheng H-F, Becker BN, Burns KD, Harris RC: Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 95:2012-2019, 1995
60. Correa-Rotter R, Hostetter TH, Rosenberg ME: Renin and angiotensinogen gene expression in experimental diabetes mellitus. Kidney Int 41:796-804, 1992
61. Kalinyak JE, Sechi LA, Griffin CA, Don BR, Tavangar K, Kraemer FB, Hoffman AR, Schambelan M: The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat. J Am Soc Nephrol 4:1337-1345, 1993
62. Jaffa AA, Chai KX, Cao J, Chao L, Mayfield RK: Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney. Kidney Int 41:789-795, 1992
63. Anderson S, Bouyounes B, Clarey LE, Ingelfinger JR: Intrarenal renin-angiotensin system (RAS) in experimental diabetes. J Am Soc Nephrol 1:621, 1990 (abstr).
64. Anderson S, Jung FF, Ingelfinger JR: Renal renin-angiotensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations. Am J Physiol 265:F477-F486, 1993
65. Velasquez MT, Kimmel PL, Michaelis OE: Animal models of spontaneous diabetic kidney disease. FASEB J 4:2850-2859, 1990
66. Everett AD, Scottt J, Wilfong N, Marion B, Rosenkranz RP, Inagami T, Gomez RA: Renin and angiotensinogen expression during the evolution of diabetes. Hypertension 19:70-78, 1992
67. Harker CT, O'Donnell MP, Kasiske BL, Keane WF, Katz SA: The renin-angiotensin system in the type II diabetic obese zucker rat. J Am Soc Nephrol 4:1354-1361, 1993
68. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45:403-410, 1994
69. Kugler P, Wolf G, Scherberich JE: Histochemical demonstration of peptidases in the human kidney. Histochemistry 83:33-341, 1985
70. Wolf G, Thaiss F, Scherberich JE, Schoeppe W, Stahl RAK: Glomerular angiotensinase A in the rat: Increase of enzyme activity following renal ablation. Kidney Int 38:862-868, 1990
71. Thaiss F, Wolf G, Assad N, Zahner G, Stahl RAK: Angiotensinase A gene expression and enzyme activity in isolated glomeruli of diabetic rats. Diabetologia 39:275-280, 1996
72. Ziyadeh FN, Goldfarb S: The renal tubulointerstitium in diabetes mellitus. Kidney Int 39:464-475, 1991
73. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 259:F704-F714, 1990
74. Rocco M, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int 41:107-114, 1992
75. 1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 267:F1094-F1101, 1994
76. 1 receptor. Nephrol Dial Transplant 8:128-133, 1993
77. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 92:1366-1372, 1993
78. Wolf G, Ziyadeh FN, Zahner G, Stahl RAK: Angiotensin II-stimulated expression of transforming growth factor beta in renal proximal tubular cells: Attenuation after stable transfection with the c-mas oncogene. Kidney Int 48:1818-1827, 1995
79. Wolf G, Killen PD, Neilson EG: Intracellular signalling of transcription and secretion of type IV collagen after angiotensin II-induced cellular hypertrophy in cultured proximal tubular cells. Cell Regul 2:219-227, 1991
80. Olbricht CJ, Geissinger B: Renal hypertrophy in streptozotocin diabetic rats: Role of proteolytic lysosomal enzymes. Kidney Int 41:966-972, 1992
81. 1 cells. Nephrol Dial Transplant 10:1305-1312, 1995
82. Schaefer L, Schaefer RM, Ling H, Teschner M, Heidland A: Renal proteinases and kidney hypertrophy in experimental diabetes. Diabetologia 37:567-571, 1994
83. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 42:647-656, 1992
84. Di Paolo S, Gesualdo L, Ranieri E, Schena FP: High glucose modulates growth factor expression in human mesangial cells. Kidney Int 47:693, 1995 (abstr)
85. Young BA, Johnson RJ, Alpers CA, Eng E, Gordon K, Floege J, Couser WG: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935-944, 1995
86. Sharma K, Ziyadeh F: The emerging role of transforming growth factor-β in kidney diseases. Am J Physiol 35:F829-F842, 1994
87. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
88. Fumo P, Kuncio GS, Ziyadeh FN: PKC and high glucose stimulate collagen α1(IV) transcriptional activity in a reporter mesangial cell line. Am J Physiol 267:F632-F638, 1994
89. Wolf G, Haberstroh U, Neilson EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107, 1992
90. Huwiler A, Stabel S, Fabbro D, Pfeilschifter J: Platelet-derived growth factor and angiotensin II stimulates the mitogen-activated protein kinase cascade in renal mesangial cells: Comparison of hypertrophic and hyperplastic agonists. Biochem J 305:777-784, 1995
91. Moriyama T, Fujibayashi M, Fujiwara Y, Kaneko T, Xia C, Imai E, Kamada T, Ando A, Ueda N: Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells. J Am Soc Nephrol 6:95-101, 1995
92. Anderson PW, Do YS, Hsueh WA: Angiotensin II causes mesangial cell hypertrophy. Hypertension 21:29-35, 1993
93. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
94. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
95. Hoffman BB, Sharma K, Ericksen M, Ziyadeh FN: Transcriptional activation of TGF-β, by high glucose. J Am Soc Nephrol 6:1041, 1995 (abstr)
96. Kreisberg JI, Radnik RA, Ayo SH, Garoni J, Saikumar P: High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell culture. Kidney Int 46:105-112, 1994
97. Shankland SJ, Scholey JW: Expression of growth-related protooncogenes during diabetic renal hypertrophy. Kidney Int 47:782-788, 1995
98. Wolf G, Heeger PS, Neilson EG: Proto-oncogenes as targets of hormone and growth-factor actions in the kidney, in Goldfarb S, Ziyadeh FN (eds): Hormones, Autacoids, and the Kidney. Contemporary Issues in Nephrology, vol 23. New York, NY, Churchill Livingstone, 1991, pp 111-139
99. Wolf G: Vasoactive substances as regulators of renal growth. Exp Nephrol 1:141-151, 1993
100. Garg UC, Hassid A: Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol 257:F60-F66, 1989
101. Sharma K, Danoff TM, DePiero A, Ziyadeh FN: Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: Possible mediation via protein kinase C. Biochem Biophys Res Commun 207:80-88, 1995
102. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide-dependent guanosine monophosphate generation in glomeruli from diabetic rats: Evidence for protein kinase C-mediated suppression of the cholinergic response. J Clin Invest 93:311-320, 1994
103. Hogan M, Cerami A, Bucala R: Advance glycosylation endproducts block the antiproliferative effect of nitric oxide: Role in the vascular and renal complications of diabetes mellitus. J Clin Invest 90:1110-1115, 1992
104. Nakayama I, Kawahara Y, Tsuda T, Okuda M, Yokoyama M: Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J Biol Chem 269:11628-11633, 1994
105. Arima S, Ito S, Omata K, Takeuchi K, Abe K: High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles. Kidney Int 48:683-689, 1995
106. Trachtmann H, Futterweit S, Singhal P: Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun 207:120-125, 1995
107. Kreisberg JI, Kreisberg SH: High glucose activates protein kinase C and stimulates fibronectin expression by enhancing a cAMP response element. Kidney Int 48:S3-S11, 1995
108. Ayo SA, Radnik R, Garoni J, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 26:F571-F577, 1991
109. DeRubertis FR, Craven PA: Activation of protein kinase C in glomerular cells in diabetes: Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1-8, 1994
110. +-ATPase, and protein kinase C activity in proximal tubule cells. Diabetes 44:446-452, 1995
111. Liu FY, Cogan MG: Role of protein kinase C in proximal bicarbonate absorption and angiotensin signaling. Am J Physiol 258:F927-F933, 1990
112. Karim Z, Defontaine N, Paillard M, Pogglioli J: Protein kinase C isoforms in rat kidney proximal tubule: Acute effects of angiotensin II. Am J Physiol 269:C134-C140, 1995
113. Kumar AM, Gupta RK, Spitzer A: Intracellular sodium in proximal tubules of diabetic rats: Role of glucose. Kidney Int 33:792-797, 1988
114. Cogan MG: Angiotensin II: A powerful controller of sodium transport in the early proximal tubule. Hypertension 15:451-458, 1990
115. Harris PJ: Regulation of proximal tubule function by angiotensin. Clin Exp Pharmacol Physiol 19:213-222, 1992
116. Tang SS, Diamant D, Rhoads DB, Ingelfinger JR: Angiotensin II (ANG II) regulates glucose uptake in immortalized rat proximal tubular cells (IRPTC). J Am Soc 6:748, 1995 (abstr)
117. Kikkawa R, Kitamura E, Fujiwara Y, Arimura T, Haneda M, Shigeta Y: Impaired contractile responsiveness of diabetic glomeruli to angiotensin II: A possible indication of mesangial dysfunction in diabetes mellitus. Biochem Biophys Res Commun 136:1185-1190, 1986
118. Kanamori A, Abe Y, Matoba K, Yajima Y: Response of cytosolic free calcium to angiotensin II in individual rat mesangial cell cultured in a medium high in glucose. Horm Metab Res 26:561-562, 1994
119. 2+ independent. Diabetes 44:759-766, 1995
120. Mene P, Pugliese G, Pricci F, Di Mario U, Cinotti GA, Pugliese F: High glucose inhibits cytosolic calcium signaling in cultured rat mesangial cells. Kidney Int 43:585-591, 1993
121. Whiteside CI, Hurst RG, Stevanovic ZS: Calcium signaling and contractile response of diabetic glomerular mesangial cells. Kidney Int 48:S28-S33, 1995 (suppl 51)
122. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and enhanced extracellular matrix gene expression in streptozotocin-induced diabetic mice. Diabetes 45:522-530, 1996
123. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator. Diabetes 44:1139-1146, 1995
124. Ziyadeh FN: The significance of tubulointerstitial changes in diabetic renal disease. Kidney Int 49:S10-S13, 1996 (suppl 54)
125. Mogyorosi A, Ziyadeh FN: Update on pathogenesis, markers and management of diabetic nephropathy. Curr Opin Nephrol Hypertens 5:243-253, 1996
126. Cohen MP, Ziyadeh FN: Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy. J Am Soc Nephrol 7:1-8, 1996